Lipopolysaccharide (LPS) induces rapid necrosis of intradermal fibrosarcomas in mice. The mechanism(s) by which LPS produces tumor necrosis has been investigated using histocompatible LPS-sensitive (C3H/HeN) and LPS-resistant (C3H/HeJ) mouse strains. C3H/HeN-or C3H/HeJ-derived fibrosarcomas were necrotized by LPS when they were grafted onto C3H/HeN mice but were not affected when growing on C3H/HeJ mice, indicating that LPS does not act directly on the tumor itself. In contrast, lethally X-irradiated C3H/HeJ mice exhibit necrosis of their tumors when reconstituted with C3H/HeN bone marrow cells, whereas C3H/HeN mice no longer exert LPS-induced tumor necrosis after the adoptive transfer of C3H/HeJ bone marrow cells. These findings clearly indicate that LPS produces necrosis of tumors by activating host lymphoreticular cells.
(C3H/HeJ) mouse strains. C3H/HeN-or C3H/HeJ-derived fibrosarcomas were necrotized by LPS when they were grafted onto C3H/HeN mice but were not affected when growing on C3H/HeJ mice, indicating that LPS does not act directly on the tumor itself. In contrast, lethally X-irradiated C3H/HeJ mice exhibit necrosis of their tumors when reconstituted with C3H/HeN bone marrow cells, whereas C3H/HeN mice no longer exert LPS-induced tumor necrosis after the adoptive transfer of C3H/HeJ bone marrow cells. These findings clearly indicate that LPS produces necrosis of tumors by activating host lymphoreticular cells.
Lipopolysaccharide (LPS, endotoxin)-induced tumor necrosis is awwell-known phenomenon (8, 13, 16) , but the mechanisms) by which this effect is mediated is not well understood. It has been suggested that LPS acts directly on the tumor cells (5) or that necrosis is due to vasoconstriction and intravascular coaggulation within the tumor (1). More recently it has been reported that LPS induces the release of a tumor necrosis factor from macrophages in vivo (7, 10) . This finding as well as others suggests that LPS exerts an influence on tumors by the production of humoral mediators (6 (12) . All statistical analyses were performed using the Fischer test (4) .
To determine if the derivation of the tumor from either endotoxin-sensitive or -resistant mice would influence its sensitivity to LPS-induced necrosis in vivo, tumors were induced with methylcholanthrene in C3H/HeN and C3H/HeJ mice and then tested in both C3H/ HeN and C3H/HeJ hosts for their LPS sensitivity. A C3H/HeN (LPS-sensitive)-derived tumor was necrotized in >70% (11/15) (Fig. 1) . These experiments indicate that the origin ofthe tumor does not influence its susceptibility to endotoxininduced necrosis and also suggest that LPS does not act directly on the tumor itself.
Since the ability to necrotize tumors with LPS is dependent upon the LPS sensitivity of the host and not on the origin of the tumor, we attempted to alter host sensitivity to LPS by Xirradiation and reconstitution of the irradiated recipient with bone marrow cells from either LPS responder or nonresponder mice. The results obtained with these chimeric mice are shown in Tables 1 and 2 nificant changes in the in vivo response oftumorbearing mice to the necrotizing effect of endotoxin. These data demonstrate that the tumor itself does not need to be LPS sensitive to be necrosed, which is strong evidence against a direct necrotic effect of LPS on the tumor. In addition, since it is extremely unlikely that the process of X-irradiation and bone marrow reconstitution would significantly alter the endothelial cells of the host, our findings argue against a direct effect of LPS on the tumor vasculature. Finally, since there is no evidence for any defect in LPS-induced complement activation in C3H/ HeJ mice, it is unlikely that LPS-induced tumor necrosis is mediated via the complement system. Therefore, the finding that adoptive transfer of bone marrow cells transfers the ability of donor cells to mediate tumor necrosis strongly suggests that LPS acts on some bone marrow-derived cell type to induce tumor necrosis. The precise cell(s) and its mechanism of action remain unclear. However, the data of Carswell et al. (7) indicate that after BCG infection and endotoxin challenge macrophages release a soluble tumor necrosis factor that exerts a cytotoxic effect on tumor cells in vivo and in vitro. Macrophages can also be activated by LPS to kill tumor cells in vitro by a mechanism that requires cell-cell contact (15 We have now demonstrated that C3H/HeJ mice can be rendered sensitive to a number of diverse LPS-induced events including lethality (9) (Michalek et al., manuscript in preparation), production of serum amyloid-associated protein (14) , interferon production (Michalek et al., manuscript in preparation), and tumor necrosis by the adoptive transfer of LPS-sensitive bone marrow cells. In addition, C3H/HeN mice can also be rendered resistant to all these effects by the adoptive transfer of LPS-resistant bone marrow cells. Thus, there is ample evidence to support the notion that the diverse manifestations of endotoxin reactions in the susceptible host require the participation of endotoxin-sensitive lymphoreticular cells and presumably a number of soluble mediators derived from such cells.
